Charles Heng MBChB, MMed, MRCP, MD

Charles Chuah Thuan Heng is currently a Senior Consultant at the Department of Haematology, Singapore General Hospital (SGH), an Associate Professor at the Cancer and Stem Cell Biology Program, Duke-NUS Medical School, and a Clinical Senior Lecturer, at Yong Loo Lin School of Medicine, National University of Singapore. He holds administrative appointments as Vice Chair of Research, SingHealth Duke-NUS Academic Clinical Program for Medicine; Director of research, SingHealth Duke-NUS Blood Cancer Centre; and Lead, of Molecular Laboratory and Myeloproliferative Disorders/Chronic Myeloid Leukemia Service, Department of Haematology, SGH.

Dr Chuah has a strong and active interest in clinical and translational research in chronic myeloid leukemia (CML) and targeted therapy for blood cancer. His research interests include mechanisms of resistance and targeted therapy in CML. In the past eleven years, he has been awarded four national grants and five institutional grants with a total funding of S$2.8 million. He was also awarded the National Medical Research Council Clinician Scientist Award in 2007 and 2010. Dr Chuah is a principal investigator in more than twenty multi-center clinical trials.

Dr Chuah has authored or co-authored over 60 publications in peer-reviewed scientific journals including Nature, Nature Medicine, Nature Genetics, New England Journal of Medicine, Cancer Cell, PNAS, Blood, Leukemia, and Journal of Clinical Oncology. He was a member of the Scientific Review Panel of the NMRC from 2007 to 2018. He was the Co-chair of the National Comprehensive Cancer Network (Asia) Consensus Statement Panel for CML in 2008.